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doi:10.1Objective: To examine the effect of regionalization of thoracic surgery services in Canada by evaluating change
over time in hospital volumes of pulmonary lobectomy and its impact on length of stay and in-hospital mortality.
Methods:Data on pulmonary lobectomy between 1999 and 2007 were abstracted from the Canadian Institute for
Health Information Discharge Abstract Database. In-hospital mortality was analyzed by logistic regression, and
log-transformed length of stay was analyzed by linear regression. Cross-sectional analysis of hospital volume, in-
hospital mortality, and length of stay was performed, controlling for clustering.Within-hospital changes in annual
volume on outcome was analyzed using multivariable logistic regression, controlling for Charlson comorbidity
index and other confounders.
Results:Of 19,732 patients, 10, 281 (52%) were male, with an average age of 63.3 years. There was a 45% (95%
confidence interval, 21–61; P ¼ .001) relative risk reduction in in-hospital mortality with a 19% reduction in
length of stay (95% confidence interval, 12–25; P<.0001). On comparison of volume between hospitals, an in-
crease of 20 cases was associated with a 15% relative risk reduction (95% confidence interval, 9–19; P<.0001)
in in-hospital mortality and a 5% relative decrease (95% confidence interval, 3–7; P< .001) in length of stay.
Within hospitals there was a nonsignificant relationship between volume and in-hospital mortality.
Conclusions: In-hospital mortality and length of stay for lobectomies have decreased in Canada. In multivariate
analysis, volume was associated with improved in-hospital mortality, but there was no reduction in mortality
when volume was increased within a given hospital. However, the proportion of patients treated in high-
volume centers has increased over time, inferring the importance of high-volume centers in improved outcomes.
This supports regionalization policies for pulmonary lobectomy. (J Thorac Cardiovasc Surg 2010;140:757-63)Earn CME credits at
http://cme.ctsnetjournals.org
The association between hospital volumes and surgical
outcomes has been well documented for many high-risk sur-
gical procedures, including surgery for lung cancer.1-4 In the
United States, a large body of evidence suggests a consistent
relationship between larger hospital volumes and improved
short-term outcomes for lobectomy and pneumonectomy.4-6
Improvements in long-term outcomes are also related to in-
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The Journal of Thoracic and Cational designation as a cancer center provides improved
outcomes beyond volume.7 The evidence for this volume–
outcome relationship is somewhat controversial, however,
because there are several studies from the United Kingdom,
Canada, and the United States that fail to show any benefit to
hospital volume on outcome in pulmonary resections.8-10
Furthermore, many smaller institutions are considered to
deliver high-quality care and have among the most favorable
outcomes reported in the literature.11
There is no universally accepted volume standard for
a large-volume center, with many publications quoting differ-
ing thresholds. The Society of Thoracic Surgeons database,12
a voluntary dedicated thoracic database, reports a median of
31.4 lobectomies per participant per year, but numbers range
from 1 to 128. Hospital lobectomy volumes ranging from 19
to 37 per year have been considered large volume,1,13 and in
Canada, Ontario has set a standard of 150 anatomic lung
resections per year as a target for high-volume centers.14 In
searching for a volume threshold above which outcomes
are improved, factors other than volume are often found to
have more influence on the variability in outcomes.15
The evidence for a positive relationship between hospital
volumes and surgical outcomes has led to the suggestion
that care be regionalized primarily in large-volume centers.16
In Canada, thoracic surgery services have been formallyrdiovascular Surgery c Volume 140, Number 4 757
Abbreviations and Acronyms
CI ¼ confidence interval
ICD ¼ International Classification of Diseases
IHM ¼ in-hospital mortality
LOS ¼ length of stay
SD ¼ standard deviation
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literature with added funding and resources being added to fa-
cilitate optimum care in 2001 and 2004, respectively.14,17 In
the largest province of Ontario, the regionalization came
with necessary requirements for facilities and availability of
specialized care. Informally, many other provinces have
amalgamated existing smaller centers to effectively
regionalize their services without explicit added resources.
Several authors caution about potential untoward side effects
of regionalization policies,11 and as yet, the effect of manipu-
lating hospital volumes on surgical outcomes for patients has
not been established. Authors theorize that patient outcomes
will be improvedby increasing an institution’s volumeor alter-
natively by referring patients to existing high-volume centers.
To address the effect of regionalization on outcomes in
thoracic surgery, pulmonary lobectomy was chosen because
it is the most commonly performed major thoracic oncologic
surgical procedure with a reported mortality ranging from
0.8% to 3.8%9,12,18,19 and a morbidity rate of 15.3% to
47%.12,18,19
The objective of this study was to examine changes in
length of stay (LOS) and in-hospital mortality (IHM) after
pulmonary lobectomy in Canada over time and to describe
relationships between these short-term surgical outcomes
and changes in hospital volumes, both between and within
hospitals.MATERIALS AND METHODS
All pulmonary lobectomies for patients age 18 years and older recorded
in the Canadian Institute for Health Information Discharge Abstract Data-
base from 1999 to 2007 were included (International Classification of Dis-
eases [ICD], 9th Revision code 44.4 for cases up to 2004, and 10th revision
code 1.GR.89.DA/NW/QB). Extended resections and bilobectomywere ex-
cluded. The Discharge Abstract Database contains all hospital discharges in
Canada with the exception of those performed in Quebec andManitoba out-
side Winnipeg. De-identified information on age, gender, admission date,
LOS, IHM, province of operation, institution number, surgeon, and patient
disposition were collected. To adjust for patient risk factors, the Charlson
comorbidity index was calculated using pre-hospitalization ICD-9 and 10
diagnosis codes,20 a method that has been validated.21,22 The study was
approved by the institutional research ethics board at the University
Health Network.
Descriptive analyses were conducted to determine the change in number
of cases performed, IHM, and LOS over time. Random effects logistic re-
gression was used for the analysis of IHM, and random effects linear regres-
sion was used for the log-transformed LOS analysis. Unadjusted regression
was performed to examine trends in outcomes over time. The effect of an-758 The Journal of Thoracic and Cardiovascular Surgnual hospital lobectomy volumes on outcomes was examined by modeling
yearly hospital volume by IHM and LOS, adjusting for calendar year, gen-
der, age, Charlson comorbidity index (each score analyzed separately),
province of care (using Ontario as the reference province), and the average
volume per hospital over the study period. An institutional increase in vol-
ume of 20 cases per year was considered clinically relevant.
We then examined the effect of changing lobectomy volumes within an
individual hospital. Both absolute yearly differences from the overall mean
per hospital and relative yearly differences from the overall mean per hos-
pital were examined in multivariate models and yielded similar results.
We present the results from the analysis using absolute differences in yearly
hospital volumes. An institutional increase in volume of 20 cases per year
was considered clinically relevant.
In the multivariate model, volumewas analyzed as a continuous variable.
To present groupings of hospitals into low, medium, and high volume, the
number of cases performed over time was examined using different thresh-
olds for ‘‘high volume,’’ ranging from 50 to 100 cases per year, and
‘‘medium volume’’ as 10 cases per year up to the threshold of ‘‘high vol-
ume.’’ After plotting the results graphically, a threshold of 60 cases per
year (or1 per week) was determined to be clinically relevant as the cutoff
for ‘‘high volume’’ because our data supported changes in time in institu-
tional numbers at this value. Low volumewas defined as fewer than 10 cases
per year or approximately 1 per month.RESULTS
The study interval from 1999 to 2007 included 19,732 pa-
tients, of whom 10,281 (52%) were male. The average age
was 63.3 (standard deviation [SD] ¼ 13.2; range, 18–94)
years. The average Charlson comorbidity index was 2.26
(SD ¼ 1.30). The average Charlson comorbidity index in-
creased over the study interval from 1.9 to 2.3. The number
of procedures performed per year increased over the study
period from 2120 to 2561, as shown in Figure 1. Preopera-
tively, 82.8% of patients had a diagnosis of cancer. A de-
crease in lobectomies in 2003 is thought to be attributable
to the severe acute respiratory syndrome outbreak.
IHM per year is shown in Figure 2. The unadjusted anal-
ysis revealed a 45% relative risk reduction (95% confidence
interval [CI], 21–61; P¼ .001) in IHM over the study period
and a 19% reduction in LOS (95% CI, 12–25; P< .0001).
The IHM yearly rate decreased over the study period from
a peak of 3.1% in 1999 to 1.95% in 2007. Similarly, LOS
yearly rates decreased from 10.4 days (SD ¼ 12.2) in
1999 to 8.9 days (SD ¼ 10.1) in 2007.
When we examined the effect of volume on mortality, we
found that hospitals performing fewer than 10 lobectomies
per year had the highest mortality at 4.8%, whereas those
performing more than 100 lobectomies per year had the
lowest mortality at 1.8% (Figure 3).
The risk-adjusted models for IHM and LOS are shown in
Table 1. Both lower IHM and lower LOS were associated
with institutions with higher volumes. After adjusting for
age, gender, and Charlson index, there was a 15% relative
risk reduction (95% CI, 9–19; P< .0001) for IHM and
a 5% relative decrease (95% CI, 3–7; P< .001) in LOS
for every 20 additional cases performed per hospital.
Table 1 shows that male gender and increasing age areery c October 2010
FIGURE 1. Number of pulmonary lobectomies in Canada per year. *Error
bars represent 95% CIs. FIGURE 3. Mortality as it relates to the number of procedures done cross-
sectionally over the entire study.
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for known patient factors and volume, year of procedure
remains a significant factor.
When examining changes in volume that occurred within
an individual hospital, there was a nonsignificant relation-
ship between increasing volumes within hospitals and
IHM, with a5% (95% CI, 6 to18, P ¼ .39) relative de-
crease in mortality for each additional 20 cases performed
within a given hospital. In contrast, there was a significantFIGURE 2. Pulmonary lobectomy mortality rate in Canada per year. *Er-
ror bars represent 95% CIs.
The Journal of Thoracic and Cadecrease in LOS, with a 4% relative decrease in LOS
(95% CI, 1–6; P ¼ .0005) for each incremental increase
in volume of 20 cases within a given hospital. There was
a significant difference in LOS between the provinces, but
not for IHM (data not shown).
The change in percentage of patients treated in centers
with different volumes over the study period is shown in
Figure 4. In 1999, 77 institutions performed lobectomies
in Canada, compared with 69 institutions in 2007. The
percentage of cases performed in ‘‘high-volume’’ centers
(>60 cases per year) increased over time from 49.7% to
65%, the percentage of cases performed in ‘‘medium-vol-
ume’’ centers (11–60 cases per year) decreased from
43.4% to 31%, and the percentage of cases performed in
small-volume centers decreased from 6.9% to 3.2%, sug-
gesting that cases overall are being increasingly performed
in high-volume centers.
DISCUSSION
This study presents the relationship between hospital vol-
umes and short-term outcomes for pulmonary lobectomy in
Canada during the study interval of 1999 to 2007. We found
a significant decrease in IHM and LOS despite increased
numbers of lobectomies performed in patients with in-
creased comorbidities. For the approximately 2600 cases
of lung lobectomies performed in 2007 in Canada, this
change results in approximately 26 lives saved and 3900 pa-
tient days in hospital avoided. It is a considerable improve-
ment in the delivery of one thoracic operation, which could
have even more profound impact when extrapolated across
other thoracic surgical procedures.rdiovascular Surgery c Volume 140, Number 4 759
TABLE 1. Multivariable regression model of in-hospital mortality and length of stay
In-hospital mortality Odds ratios Lower 95% Upper 95% P value
Yearly mean
volume (per patient)
0.992 0.989 0.995 <.0001
Relative volume 1.003 0.997 1.008 .3899
Calendar year 0.952 0.916 0.989 .0107
Gender (male) 1.753 1.435 2.142 <.0001
Age (per 10 y) 1.628 1.482 1.788 <.0001
Charlson ¼ 1 0.396 0.227 0.694 .0009
Charlson ¼ 2 0.27 0.205 0.356 <.0001
Charlson ¼ 3 0.402 0.292 0.555 <.0001
Charlson ¼ 4 1.371 0.832 2.258 .2064
Charlson ¼ 5 0.258 0.169 0.393 <.0001
Charlson ¼ 6þ 1.009 0.535 1.9 .9785
Length of stay Odds ratios Lower 95% Upper 95% P value
Yearly mean
volume (per patient)
0.997 0.996 0.999 <.0001
Relative volume 0.998 0.997 0.999 .0005
Calendar year 0.982 0.979 0.986 <.0001
Gender (male) 1.033 1.016 1.05 .0001
Age (per 10 y) 1.098 1.09 1.105 <.0001
Charlson ¼ 1 1.087 1.039 1.137 .0001
Charlson ¼ 2 1.003 0.974 1.034 .4097
Charlson ¼ 3 0.998 0.964 1.033 .4436
Charlson ¼ 4 1.369 1.26 1.487 <.0001
Charlson ¼ 5 1.037 0.998 1.078 .0297
Charlson ¼ 6þ 1.39 1.273 1.518 <.0001
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creases with increasing volume when comparing between
hospitals, there is no effect on mortality when individual
hospitals increase their volumes. Furthermore, we observed
both a decrease in overall adjusted mortality over time and
an increase in volumes in those hospitals performing high-
volume procedures over time, similar to US reports.23,24
Although the total volume of cases increased over time
could explain this, only 5.6% of institutions crossed from
the medium-volume institutions to high-volume institutions.
Thus, it is likely that the decrease in mortality is associated
with a larger proportion of lobectomies being delivered in
high-volume centers and the cessation of the lower-
volume institutions with their associated average higher
mortality. This suggests that for lobectomy in Canada, the
volume–outcome relationship is best optimized by selective
referral to existing large-volume institutions.
Factors affecting mortality include patient factors and the
average procedural volume of the hospital where the lobec-
tomy is performed. Patient and volume characteristics seem
to be changing over time with overall increasing Charlson
comorbidity index and proportion of patients being treated
in high-volume centers, whereas age is relatively stable.
However, mortality is improving over time beyond that ex-
plained by these factors. Whether this added effect reflects
improved staging, surgical selection, or early interventions760 The Journal of Thoracic and Cardiovascular Surgon critically ill patients25 is unclear. The increasing avail-
ability of video-assisted lobectomy offers a potential surgi-
cal factor that may contribute to improved outcomes in
larger institutions, but the adoption of this technique in Can-
ada is still ongoing, and with the limitations of the coding, its
effect is inaccessible. A shift in procedures to high-volume
hospitals is the sole potentially externally modifiable vari-
able. Indeed, there has clearly been a movement of patients
to higher-volume centers.
Our study also addresses the question of what occurs to
outcomes when the volumes in individual centers change.
Notably, increasing an individual center’s volume failed to
show any change in mortality, but a significant improvement
in LOS was observed when individual hospital volumes in-
creased. LOS is frequently used as a marker of quality of
care, with reduced LOS representing a surrogate marker
for improved management of patients, including preopera-
tive patient selection, operative care, postoperative course,
and reduced complications. Its improvement with increased
hospital volumes may represent change in practice over time
or improved efficiency of care in response to healthcare
economic pressures.
Study Limitations
Our study has several limitations. Accounting for case-
mix and comorbidity is required in volume–outcomeery c October 2010
FIGURE 4. Changing percentage of patients treated at centers with differ-
ent volumes.
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the Charlson comorbidity index, which has been validated
for population-based studies and used elsewhere in vol-
ume–outcome research. Its use, however, of comorbid ill-
nesses, such as congestive heart failure, diabetes, human
immunodeficiency virus, renal failure, and cancer, does
not include all accepted factors that increase the risk of pul-
monary resection. Other important markers, such as forced
expiratory volume in 1 second, carbon monoxide diffusion
in the lung, and exercise testing, are not available in the Ca-
nadian Institute for Health Information database and are not
part of the Charlson index. In our study, IHM and LOS did
not change uniformly with progressive Charlson comorbid-
ity scores as would be expected. This could be explained by
the expected worse outcomes in patients undergoing ana-
tomic lung resection for inflammatory reasons, many of
whom would have a correspondingly lower Charlson score.
As such, each score was analyzed separately and not linearly
to account for this effect. Furthermore, although the Charl-
son index accounts for malignancy, we do not have stage in-
formation in our database, which limits our ability to control
for patients with more advanced disease, although arguably
this should not affect short-term outcome in well-selected
patients.
There was a coding change from ICD-9 to ICD-10 over
the course of our study, which was incorporated at different
times in each province. The ICD-10 coding system is more
detailed than the ICD-9 system, and thus it is possible that
the same spectrum of cases was not captured by our use of
the ICD-10 codes as was captured for the use of ICD-9
codes. Because the results were consistent across the study
period, however, this is likely not a significant factor. The
Charlson comorbidity index is formed from ICD coding,
but it has been shown that the change in coding did not affect
its performance in capturing comorbidity.20-22The Journal of Thoracic and CaThere has been active promotion of the concept of region-
alization of thoracic surgery services to high-volume centers
based on the quantity of cross-sectional evidence for vol-
ume–outcome relationships. Our results support the cross-
sectional relationship between short-term outcomes and
higher-volume centers. In addition, we show that, over
time, there has been an improvement in short-termmortality,
and this change is in part due to more cases being done
in higher-volume centers rather than within-hospital
improvement. These results support the idea that services
should continue to be regionalized to high-volume centers.
However, regionalization is clearly more than just volume
and includes other processes of care that we have not mea-
sured, such as specialized services, staff, and experience.
This study suggests that systematic initiatives in regionaliza-
tion of thoracic surgery are moving us forward in improving
outcomes of patients undergoing lobectomy. It also under-
scores the importance of outcome data collection and analy-
sis going forward to accurately assess the efficacy of our
attempts to improve the quality and efficiency of health
care delivery.
CONCLUSIONS
During a period when several initiatives were imple-
mented to improve patient care in thoracic surgery in Can-
ada, IHM and LOS for pulmonary lobectomies decreased.
High-volume centers demonstrated significantly improved
overall outcomes. Although increased volume within a hos-
pital was related to decreasing LOS, we did not find a signif-
icant relationship between mortality and changing yearly
volume within a given hospital. The proportion of patients
treated in high-volume centers has increased over time,
and volume is associated with improved outcome in the
multivariate model. These results infer an important role of
high-volume centers in improved LOS and IHM. Our results
support the policy that services should continue to be region-
alized to high-volume centers. They also underscore the im-
portance of prospective outcome data analysis to accurately
assess the efficacy of efforts to improve quality and
efficiency of health care delivery.
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Dr Yolonda Colson (Boston, Mass). You are to be commended
for your analysis of IHM and LOS in approximately 20,000 patients
undergoing lobectomy in Canada during a time of transition to re-
gionalization of thoracic surgical services. Your study demon-
strates an impressive 45% relative risk reduction in IHM and
a 19% reduction in LOS that was associated with an increased num-
ber of cases being performed at large-volume centers, alluding to
the benefits of regionalization. Although an increase in the number
of cases within a hospital did decrease LOS, it did not lead to a de-
crease in mortality, suggesting that an increase in volume alone is
not the sole answer.
In an attempt to better understand these observations and their
applicability to other scenarios and health care systems, I have
3 questions based on your presentation and article.762 The Journal of Thoracic and Cardiovascular SurgFirst, would you please describe how regionalization was initi-
ated and carried out in Canada, because we are not as familiar
with that, and how it relates to the data that you presented? For ex-
ample, was the transition gradual or does a conscious mandated
shift of patients to large-volume centers account for the abrupt in-
crease in the percentage of cases done at high-volume centers that
starts in about 2005 as demonstrated in your article, and can you
comment on the driving force behind the marked increase in the
number of lobectomies that you noted starting in about 2003?
Dr Finley.Canada delivers health care on a provincial basis, and
so the regionalization process occurred in differing ways and differ-
ent scenarios in each province. The first to begin was British Co-
lumbia, which made a political decision in 2001 but did not
begin to enact it until about 2003. They were very organized about
it and moved different physicians to centralized centers and added
resources to those centers. Alberta was more informal and did not
have a formal regionalization process, but did move surgeons into
centralized locations. Ontario, with the largest population, has had
the biggest effect. About 2004, Ontario started the process, which is
still ongoing. That is probably why we see the largest change in
volume at the tail end because of the study period.
With regard to the numbers of lobectomies being performed, cer-
tainly the incidence of lung cancer is cresting in Canada and it only
goes up approximately 1% per year, so it wouldn’t explain the in-
crease in volume performed. I didn’t present the data, but over this
time frame, the number of pneumonectomies has decreased signif-
icantly from approximately 500 per year to approximately 250 per
year. So this would be a potential explanation—surgeons operating
on those patients are trying to do more limited resections. Alterna-
tively, patients are being referred to these high-volume centers
where they are getting multidisciplinary evaluation and not short
circuiting the surgeon and going directly into radiation or medical
oncologists. These are potential explanations.
Dr Colson. So was it done as a mandate or a financial incentive
if it was a high-volume versus low-volume center?
Dr Finley. Increased funding was involved in almost all the re-
gionalizations. Certainly in Ontario and British Columbia it is and
was an incentive-driven process, but in other provinces it was more
informally done without additional costs.
Dr Colson. The second question. You have stated that the de-
crease in IHM during this time period is likely related to the shift
of cases from low- to high-volume centers. However, given that
there is a 20% increase in the total number of lobectomies over
the course of your study, couldn’t it be that the increased percentage
of lobectomies done at high-volume centers is also just because
there are more cases for everyone, and therefore more mid-level
centers now qualify as high-volume centers as they cross the case
threshold of 60?
Dr Finley. Certainly there is a proportion of patients and facili-
ties that cross that threshold, but the majority of the effect we saw
was in the reduction of those low-volume centers going out of the
business, the reduction of the number of institutions performing it.
Dr Colson. There is an obvious dichotomy between the dra-
matic increase in mortality associated with an increasing number
of patients being treated in high-volume centers, but there is no
decrease in mortality associated with increasing the volume at
a specific hospital, correct?
Dr Finley. Yes.ery c October 2010
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answer to everything, does your study reflect that the most impor-
tant benefit of regionalization may actually be the shifting of more
cases to low-mortality hospitals, and thus the overall decrease is
reflecting more cases done at these low-mortality hospitals, in
essence? Is there any insight that you have gained as to how to
make these high-volume centers really low-mortality centers?
Dr Finley. That is a good point, because there are a number of
small-volume centers that have excellent results with low mortal-
ities. However, on average the larger-volume hospitals deliver bet-
ter outcomes. Clearly a lot goes into the mortality of a patient
beyond the surgeon’s involvement. We are intimately involved in
our patients’ care, but a number of people become involved in their
outcomes, from the nursing ratios on the floor to the level of mon-
itoring the patients are undergoing to the ability of rescue. I think
one of the most influential articles I read in the last year was by
Amir Ghaferi, in The New England Journal of Medicine, who sug-
gested that the difference between a low-mortality hospital and
a high-mortality hospital had nothing to do with complication rates,
which were exactly the same. It was the ability of rescue; it was the
ability to pull those patients out of the fire once the morbidity oc-
curs. I think that is an area of research that needs to continue and
be ongoing, because if you don’t have 24-hour intensive care or
somebody in-house who is experienced with these patients, then
you can miss an opportunity to intervene.
Dr Colson. Thank you.
Dr Thomas Egan (Chapel Hill, NC). I enjoyed your presenta-
tion, but some of your conclusions are based on the accuracy of
coding. In the United States there is a financial incentive for hospi-
tals to code more, and I am curious to know across the provinces
during the time of your study, were there any financial incentives
and did you notice an increase in the number of ICD-9 codes
over time?
Dr Finley. There certainly was an increase in the Charlson co-
morbidity index as it relates to the ICD-9 and 10 codes. Hospitals
in some provinces are remunerated on the comorbidities of their pa-
tients, so there could be a slight trend there. That said, the Canadian
Institute of Health information goes back and examines the hospi-
tals on their coding systems and publishes regular reports on the ac-
curacy and validity of those reports, and it has actually been quite
reliable. That said, within our data it is internally consistent from
year to year, so I don’t think there was a drift in that way.
Dr Paul Waters (Greenwich, Conn). My question is a specific
question about a patient, John Smith. John Smith goes to a small-
volume hospital, say 10 cases per year, and dies. That hospital
now has a 10% mortality. He goes to a big hospital, bigger center,
say 100 cases per year, and dies. That is a 1%mortality. So it seems
that smaller centers are kind of inherently disadvantaged. It is a bit
like setting up a transplant program. If you do a small volume the
first year and have a mortality, you have a bad set of numbers.The Journal of Thoracic and CaYou probably mentioned this in your talk and I zoned out, but
I would like to hear your response to that.
Dr Finley. As I said, there are some tremendous small-volume
hospitals, and I think all of us worry about how to evaluate institu-
tions in a fair way, and that is why on a population basis we look at
all the hospitals lumped together. There are hospitals that do a very
good job, and trying to elucidate which hospitals actually have a sta-
tistically significant deviation from an acceptable threshold is diffi-
cult to do in real life, because a hospital that performs 10
lobectomies per year would require 4 or 5 years of evaluation to
know if they actually drifted off of statistically acceptable level.
So you are right, in a given year in a given hospital, it is unfair to
disadvantage them, but this is a population-based study, so we
are looking from 20,000 feet and lumping those groups together.
DrWaters. So that small hospital you looked at for 5 years, and
your threshold for acceptable was 6%, it is going to be an unaccept-
able center on the basis of those numbers, isn’t it, if it has a single
mortality per year? It is not an argument.
Dr Todd Demmy (Buffalo, NY). This regionalization was coin-
cident to the popularity rise in thoracoscopic lobectomy, which has
been shown to have a similar reduction in hospital stay, also a reduc-
tion in complications, which for a group who may be getting sicker
might have contributed to some of these outcomes. Did you look at
the proportions of thoracoscopic lobectomy to open in your groups?
Dr Finley. No, we were unable to do that, but I agree with you
that different technologies have an effect here. Minimally invasive
thoracic surgery and improvements in intensive care, perioperative
evaluation, and better staging all help, so we are picking patients
who do better. These could all have influenced the outcome.
Dr Valerie Rusch (New York, NY). The optimum care of these
patients is really a team effort, demanding excellent care from the
anesthesiologist team and nursing team. Do you have any way of
examining that in your analyses and has there been any regionali-
zation effort to develop specific nursing support services or the des-
ignation of thoracic anesthesia teams to optimize the care of these
patients that might also affect your results?
Dr Finley. It is difficult to evaluate from this study, but certainly
different provinces have enacted different systems of care as they
have taken on this process. In British Columbia, again, with the
concentration of specialized surgeons, there has been specialized
nursing and education in those centers. In Ontario, again with the
concentration of care and incentives to the hospital, those other vital
services are strengthened. There are guidelines that were published
in The Annals of Thoracic Surgerywith recommendations for a sin-
gle-payer system, and they listed a number of criteria that would be
useful for those regionalized centers, including 24-hour interven-
tional radiology, intensive care, and ancillary staff such as special-
ized nursing and respiratory therapy. But I agree with you that
specialized nursing and specialized anesthesia go a long way to
improving that care.rdiovascular Surgery c Volume 140, Number 4 763
